Douglas Kwon is a physician scientist at Harvard Medical School, Director of Clinical Operations at the Ragon Institute of MGH, MIT and Harvard, and Associate Director of the Harvard Center for AIDS Research. He has a clinical practice in the Division of Infectious Diseases at Massachusetts General Hospital. He received his M.D. Ph.D. degrees from New York University and then underwent Internal Medicine training at the University of California, San Francisco and New York Hospital/Weill Cornell Medical Center. He completed his training in the combined Massachusetts General Hospital and Brigham and Women’s Hospital Infectious Disease fellowship program. The focus of his current research is understanding the role of mucosal tissues in HIV acquisition and disease progression. His lab is involved in developing and applying new technologies to overcome the technical barriers that have impeded our understanding of mucosal immunity to date. This includes the application of novel techniques and functional assays to assess HIV-specific immune responses and the microbiome at mucosal sites.
At the completion of this educational session, learners will:
- Understand the impact of treated and untreated HIV on the mucosal immune system and its role in HIV disease progression.
- Learn about the role of the bacterial microbiome and virome on HIV susceptibility and HIV-associated chronic inflammation.
- Understand the latest efforts to leverage the microbiome to prevent HIV and improve health for those living with HIV.
This CME activity was approved for AMA PRA Category 1 Credit™
on May 15, 2018 and will terminate May 14, 2021.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Douglas Kwon (Presenter) has no relevant financial relationships to disclose. Dr. Kwon submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the PRN Courses Page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.